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Few studies have compared preference values of health states obtained in different  
countries. This paper applies a nonparametric model to estimate and compare EQ-5D  
health state valuation data obtained from two countries using Bayesian methods. The  
data set is the US and UK EQ-5D valuation studies where a sample of 42 states  
defined by the EQ-5D was valued by representative samples of the general population  
from each country using the time trade-off technique.  We estimate a function  
applicable across both countries which explicitly accounts for the differences between  
them, and is estimated using the data from both countries. The paper discusses the  
implications of these results for future applications of the EQ-5D and further work in  
this field.  
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 1. Introduction 
There has been an increasing use of preference-based measures of health related 
quality of life in order to calculate quality adjusted life years (QALYs) for use in cost 
effectiveness analyses. These preference-based measures are standardised multi-
dimensional health state classifications with preference or utility weights elicited from 
a sample of the general population (Brazier et al, 2007a).  There are currently a 
number of such preference-based measures, including the generic EQ-5D (Brooks, 
1996), HUI2 & 3 (Torrance et al, 1996; Feeny et al, 2002), 15D (Sintonen, 1994, 
1995), AQoL (Hawthorne et al, 2001), QWB (Kaplan et al, 1988) and the SF-6D 
(Brazier et al, 2002) and condition specific preference-based measures have also been 
developed (Revicki et al, 1998; Brazier et al, 2007b).  These measures provide 
empirically derived health state value that can be used to derive QALYs for use in a 
cost-effectiveness analysis (Drummond et al, 2005).  
The EQ-5D has become one of the most widely used measures of health status and it 
has been valued in the most countries of any of the generic preference-based 
measures.  There is a concern that valuations may differ between countries due to 
differences in culture or health care delivery systems, thus invalidating the use of 
values obtained from one country in another. Earlier research with the EQ-5D found 
quite small and largely unimportant differences between UK, US and Spain (Johnson 
et al, 2005 and Badia, et al, 2001).  A valuation of the HUI3 in France also found little 
difference with the Canadian data set.  Using a much larger valuation data set 
obtained using the TTO from a representative sample of the US population, Johnson 
et al (2005) found that differences in EQ-5D health state valuations between the 
United States and United Kingdom general populations are potentially important. This 
paper extends their work by using a new nonparametric Bayesian method to model 
the differences between these countries that is simpler, a better fitting and more 
appropriate for the data that the conventional parametric of Johnson et al (2005). The 
objective of the study is to compare the directly measured US population-based EQ-
5D health state valuations with those generated in the UK population survey and to 
investigate whether the valuations differ between the two populations and, if so, how. 
Section 2 of this paper provides a brief description of the US and UK EQ-5D 
valuation surveys and the data used in this paper.  Section 3 sets out a Bayesian 
nonparametric model that we believe provides more realistic and flexible inference 3
for preference functions. Section 4 presents the results of using the Bayesian method 
using the US/UK EQ-5D data set. We conclude with a general discussion of the 
results in Section 5 including some directions for future research in the merging field 
of cross country valuation. 
2. EQ-5D data set  
This instrument has a structured health state descriptive system with five dimensions 
of mobility, self-care, usual activities, pain/discomfort and anxiety/depression 
(Brooks, 1996). Each dimension has three levels of no problem (level 1), moderate or 
some problem (level 2) and severe problem (level 3).  Together these 5 dimensions 
define a total of 243 health states formed by different combinations of the levels (i.e. 
3
5), and each state is described in the form of a five-digit code using the three levels 
(e.g. state 12321 means no problems in mobility, moderate problems in self-care, and 
so on).  
The most widely used scoring algorithm has been estimated from the valuation survey 
undertaken by the UK Measurement and Valuation of Health (MVH) group at York.  
They used a variant of the VAS and TTO in an interview survey of the UK general 
population (response rate 56%).  Respondents were interviewed in their own home 
using TTO and VAS to each value 13 states.  In all 43 EQ-5D states were valued in 
this way. Regression techniques were used to model these data to estimate additive 
functions with decrements for the moderate and severe dysfunctional categories of the 
five dimensions, a constant term for any kind of dysfunction and the term ‘N3’ for 
whenever any of the dimensions are severe  
The US study used the same set of states and valued them using the same valuation 
methods.  However, whilst the UK valuation study employed a simple sampling 
design, the US study used a 4-stage, cluster sampling strategy, with over sampling of 
the 2 largest minority groups, Hispanics and non-Hispanic blacks (Shaw et al (2005). 
A total of 4048 (response rate: 59.4 %) and 3395 (response rate: 64 %) respondents 
were interviewed in the US and UK studies, respectively. Respondents were excluded 
with incomplete or inconsistent responses and this resulted in usable valuation data 
from 3773 and 2997 respondents. These samples were found to be reasonably 4
representative of their populations in terms of sociodemographic characteristics 
(Dolan, 1997; Shaw et al, 2005). 
Each respondent was asked to value 12 EQ-5D states.  The US and UK studies 
differed in the way the 42 states were allocated across respondents. In the UK 41 
health states (excluding 33333) were divided into 4 groups by severity of problems 
and each respondent was randomly assigned 2 "very mild," 3 "mild," 3 "moderate," 3 
"severe" states, plus 33333. US respondents were randomised to get 1 of 5 groups of 
predefined health states: four groups were the modelling sample that each included 
33333, 2 randomly selected "very mild" states (i.e. 21111, 12111, 11211, 11121 or 
11112), and 9 states randomly selected from the remaining 36 states. The 5
th group 
(i.e. the validation sample) consisted of 33333 and 11 health states randomly selected 
from the remaining EQ-5D states. All UK respondents were interviewed in English 
while in the US respondents could be interviewed in English or Spanish.  
As in Johnson et al (2005), US and UK data have been pooled along with extra 
variables defined to reflect sampling designs of the two studies. The pooled data can 
is treated as coming from one study in which the population is first stratified into the 
US and UK sub-groups.  
3. Modelling 
The aim of modelling is to estimate health state utility values for all states for the EQ-
5D from the 42 valued states. .  The utility associated with a health state is assumed to 
be a function of that state, hence by estimating a relationship between the descriptive 
system and the observed values we can infer values for all states. Valuation surveys 
generate data with a complex structure creating a number of problems for estimation 
and a variety of techniques have been used to deal with these problems (Brazier et al, 
2002).  In the main these have used parametric relationships with particular 
assumptions about functional form, but here we contrast this parametric approach 
reported by Johnson et al (2005) with a more realistic and flexible nonparametric 
model.  
A general model for health state valuations can be described by (Kharoubi et al, 
2005): 
) , (x ,   (1)  5
where, for   = 1, 2, …,   and    = 1,2, …,  , x  is the 
th health state valued by 
respondent   and the dependent variable   is the TTO valuation given by respondent 
for that health state. The general model has two sets of independent random effect 
terms:   is a random error, zero-mean, term associated with each observation and 
 is a term to allow for individual characteristics of respondent  .   
The interpretation of  ) , (x  is as the true indifference TTO value that respondent 
has for health statex . The objective is to obtain a health state utility measure for the 
population as a whole, and this is generally taken to be the mean of the respondent-
level health state utilities across the population.  In order to account for different 
populations, it is possible to model   in terms of respondent-level covariates such as 
age, gender or socio-economic factors (Kharoubi et al, 2007).  In the present study, 
we include nationality as a covariate. 
3.1 The parametric approach  
Johnson et al (2005) specify the following model for respondent  ’s health state 
utility: 
) ( ) , (x I x ,   (2) 
where   and   denote unknown parameters,   is a term to allow for individual 
characteristics of respondent  Johnson et al (2005) included four terms their model 
(1): respondents’ national identity, sex, age and age-squared. 
) (x I  is a vector of dummy explanatory variables. In the simplest, no-interactions, 
case of this model,  ) (x I  is a vector of terms  ) (x  for each level   of 
dimension   of the EQ-5D.  For example,  ) ( 32 x  denotes dimension   = 3 (usual 
activities), level   = 2 (moderate problems).  For any given health state  x ,  ) (x  is 
defined as: 
) (x  = 1 if, for state x , dimension   is at level 
) (x  = 0 if, for state x , dimension   is not at level 6
In all, there are 10 of these terms, with level   = 1 acting as a baseline for each 
dimension. Hence the intercept parameter   represents the health state utility value 
for state 111111, and summing the coefficients   of the ‘on’ dummies derives the 
value of any other state.  
More generally,  ) (x I  can include additional dummy variables to account for 
interactions between country and valuation predictors.  Model (2) estimated by 
Johnson et al (2002) includes country-specific effects on these valuation predictors 
(through interaction terms) together with a constant country-specific effect across all 
health states (through a national identity term).  This model had a further 13 variables 
resulting in 27 in all. 
Estimation of this random effects model is via generalised least squares or maximum 
likelihood and so the population health state utility for state x in this model is 
simply) (
^ ^
x I . 
3.2 The nonparametric approach  
The models used in all previous analyses have, like (2), been parametric. They have 
therefore imposed a particular form on the utility function. Kharroubi et al. (2005) 
propose to use a nonparametric approach that allows the function to take any form, 
employing Bayesian hierarchical modelling.  
The Kharroubi et al. (2005) model describes the intrinsic characteristics of individual 
health state valuation data in a way that is argued to be more theoretically appropriate 
than previous parametric models. For respondent  , the health state utility of state  x
is
) ( 1 ) exp( 1 ) , ( x x  .   (3)  7
Note that the individual respondent term   enters multiplicatively rather than 
additively as in Johnson et al (2005).  The term  (x) is the  health state utility 
of health state x.
1 The mean health state utility is  
) ( 1 1 ) (x x  , 
where   is the mean value of  ) exp(  over the whole population.  This will not in 
general be 1, and so the population (mean) health state utility is not the same as the 
median health state utility  (x). More details of the nonparametric modelling and 
evaluation of   are given in Kharroubi et al. (2005). 
Kharroubi et al (2007) extended this model to allow the individual respondent effects 
to depend on covariates representing respondent characteristics, such as age, sex or 
educational status, through the further equation  
) , (
2 '   (4) 
where t is the vector of covariates for respondent   and   is the vector of coefficients 
for the covariates. Note here that t’s are centered to ensure that they have zero means, 
and hence that the value of  ) exp(  for a typical person is 1.  Note also that different 
subpopulations will have different distributions for the covariates, and hence will have 
different values of  .  The model thereby provides a natural way to estimate utility 
functions appropriate to different subpopulations. 
For the problem of interest, we wish to model specifically the particular ways in 
which respondents in the US value health differently from those in the UK.  First, we 
can treat being a US or UK respondent as a covariate, using (4).  This allows both 
populations to share an underlying utility function  (x), but for US respondents to 
differ systematically from UK respondents in how they individually value health.  
Through additional interaction covariate terms, we can allow this systematic 
difference to depend on age, sex, or other covariates.  However, it is possible that the 
differences between the two cultures are more subtle than this, and for instance US 
respondents may give lower utility values for poor health in one dimension but higher 
utilities when health is compromised in a different dimension.  We therefore allow for 
1 In the Kharroubi et al (2005) model, the distribution of   is normal, so it has zero median as well as 
zero mean, and the median of  ) exp(  is therefore 1. 8
this kind of dimension-specific difference in the two utility functions via the 
following amendment to the model (3): 
) ( 1 ) exp( 1 ) , ( x x ,(5)  
where the term  (x) in (5) is theutility of health state x in country c (c = 1 if US 
respondent; 0 if UK respondent), and is represented as: 
) ( ) ( 0 0 x x x ,                          (6) 
) ( ) ( ) ( ) ( 1 0 1 x x x .  (7) 
The expressionx 0  in (6) expresses a belief that the underlying utility function 
) ( 0 x  for UK respondents will tend to behave like a simple linear combination of the 
elements of the health state description vector x.  The coefficients   (which we 
expect to be negative) represent rates at which utility generally declines when we 
increase the level in the corresponding dimension of x.  The comparable expression in 
(7) modifies these underlying trend variables with additional coefficients to reflect 
dimension-specific differences between the US and UK.   
The term ) (x  represents a deviation from the simple linear trend that is common to 
both UK and US respondents.  As in Kharroubi et al. (2005), ) (x  is treated as an 
unknown function and in a Bayesian nonparametric framework it therefore becomes a 
random variable.  It has zero mean, constant variance and is constrained by a 
correlation between ) (x  and ) (x  for two different states x and  x  which decreases 
as the distance between x and  x  increases.  The effect of this is to assert that if x and 
x  describe very similar health states (in the sense that their levels are the same or 
close in all dimensions) their utilities will be approximately the same, and so the 
preference function varies smoothly as the health state changes.   
Note that the inclusion of a US/UK covariate in (4) means that the median value of 
) exp(  in given country will not in general be one and so, unlike (3),  (x) is not the 
health state utility
2.  
2 Here the distribution of   is defined by (4), so its median is not zero, and the median of  ) exp(
is therefore different than 1. This shifts the median utility in both models. 9
4. Results  
For this analysis the vector of covariates is set to be (US, Age, Age2, Sex, US*Age, 
US*Age2, US*Sex) where US is a dummy variable to differentiate respondents’ 
national identity (1 if US respondent; 0 if UK respondent) and Age2 is squared age. 
To further investigate how valuations differ between the two countries, the interaction 
terms US*Age, US*Age2 and US*Sex are included. Table 1 shows the posterior 
mean and standard deviation for population mean utility of the 43 health states in the 
US and UK. US mean valuations are higher than the UK valuations for all heath 
states. Predicted mean valuations for the 43 EQ-5D health states ranged from              
-0.2671(33333) to 1(11111) for the US population and from -0.5613 (33333) to 
1(11111) for the UK population. This difference is also obvious from Figure 1 which 
shows the predicted mean health state valuations (line marked with diamonds) for the 
US population along with the predicted mean health state valuations (line marked 
with squares) for the UK population. The line marked with triangles represents the 
difference between the two valuations. As can be seen, the US and UK valuations are 
very similar for mild health states; whereas for intermediate and severe health states 
the US values are higher than the UK ones.  The (US-UK) differences in the posterior 
means for the true population mean utilities ranging from 0 (11111) to 0.2942 
(33333). Finally, posterior means for the true population mean valuations of 9 health 
states are less than zero for the US whereas negative posterior mean valuations are 
present for 17 health states for the UK population. We compare these results with the 
results of Johnson et al (2005) later in this section. 
Figure 2 shows the posterior distributions of the covariates (US, Age, Age2, and Sex). 
As can be seen, these distributions are concentrated away from zero which indicates 
that these covariates have important effects.  Note that the age (and age squared) and 
sex effects are consistent with those previously found for SF-6D (Kharroubi et al, 
2007).  The main additional finding here is that the US covariate has a substantial 
effect. Figure 3 shows the posterior distributions of the interaction terms US*Age, 
US*Age2 and US*Sex. There appears to be a substantial interaction between US/UK 
and sex. The magnitude is about 0.05, whereas the marginal sex effect is about -0.04 
(Figure 2). Given the marginal sex effect and interaction effect are of opposite signs 
and of comparable size, this means that there is little net effect from the sex variable 10
in the US. Figure 4 shows the mean TTO utility values by age for the pits state 
(33333) for both the US and UK. We see that US posterior means for the true 
population mean valuations for both males and females are higher than the UK 
valuations for this health state. We also see that the line marked with squares is very 
close to the one marked with diamonds which also indicates that the sex effect in the 
US is small. The big difference between the line marked with triangles and the one 
marked with stars shows an appreciable sex effect in the UK. Finally, the age effect 
seems larger in the UK but this does not appear to be a substantial interaction 
(between US/UK and age) as the magnitude is about 0.004 (Figure 3), whereas the 
marginal age effect is about -0.004 (Figure 2). 
Figure 5 shows the posterior distributions of the underlying regression parameters in 
(6) i.e.   and  .The first element is the coefficient of the constant term  , but the 
other 5 elements represent slopes of   as each of the 5 dimensions (mobility, self-
care, usual activities, pain/discomfort and anxiety/depression) increases. We see that, 
with high probability, all of these 5 coefficients are negative, so the fitted parametric 
relationship for the UK satisfies monotonicity. Figure 6 shows the posterior 
distributions of the elements of the corresponding   and   in (7). The first element is 
the change   in the constant term between the UK and US and the other 5 elements 
represent changes in slope   as each of the 5 dimensions increases. We see that all 
these parameters have posterior distributions strongly to one side of the zero value, 
indicating that there are genuine differences between the US and UK in how 
individuals respond to poor health in each of the five dimensions.  Note, however, that 
for the first two dimensions (Mobility and Self Care) the differences are negative, 
indicating that US respondents are more sensitive to poor health in these dimensions, 
whereas positive differences in the other dimensions suggest that the US respondents 
were less concerned about Usual Activities, Pain/Discomfort or Anxiety/Depression 
than their UK counterparts.  We also note, however, that the magnitudes of these 
parameters are much smaller than the corresponding   parameters and so this 
indicates rather small differences between UK and US.  
Figure 7 presents the predicted mean health state valuations (line marked with 
diamonds) for the US population obtained by Johnson et al (2005), along with the 
predicted mean health state valuations (line marked with squares) for the UK 
population. The line marked with triangles represents the difference between the two 11
valuations. In comparison with Figure 1, Figure 7 shows more disordered behaviour. 
Estimated mean valuations for the 43 EQ-5D health states ranged from -0.38(33333) 
to 1(11111) for the US population and from -54 (33333) to 1(11111) for the UK 
population. The (US-UK) differences in population means range from -0.01 (21111) 
to 0.25 (21232). In addition, mean valuations of 8 health states are less than 0 for the 
US whereas negative mean valuations are present for 16 health states for the UK 
population.  We found that the maximum difference between the two approaches is 
0.1109, for pits health state, whereas the difference on average is 0.039 (Table 1).  
Figure 8 presents the relationship between the US and UK predicted posterior means 
for the true population mean valuations of the 43 EQ-5D health states. The solid 
reference line is a line of unity. This figure shows that the magnitude of the 
differences in US and UK population mean valuations increased with decreasing 
valuations of these health states. In comparison with Figure 8, Figure 9 presents the 
corresponding relationship obtained by Johnson et al (2005). 
As always, it is important to check the validity of the assumed model (3). Figure 10 
plots a histogram of standardised residuals across all 81240 health state valuations for 
the Bayesian model. According to this model we would expect these to have 
approximately a standard normal distribution. Figure 10 broadly supports this, 
although there is some evidence of skewness. This is not surprising, given the 
negative skewness in the original TTO data at the individual level. However, the 
degree of skewness is probably not high enough to invalidate the analysis in our 
model, which assumes normally distributed errors.  
A better test of the validity of the model is to investigate its ability to predict the 
values for states that have not been used in the estimation. Data relating to 3 selected 
health states (5204 observations) were removed randomly from the estimation data, 
and the models fitted on data for the remaining 40 states (76036 observations). Table 
3 presents the true sample means for the 3 omitted states, together with their predicted 
mean and standard deviation values from the nonparametric model estimated on the 
reduced data set.  The predictive performance of the nonparametric model is better 
than the parametric model overall, with root mean square error (RMSE) of 0.040 and 
0.168, respectively.  It can be seen that the nonparametric model predicts the omitted 
data quite well. It is to be noted that the predictive standard deviations here are larger 12
than those in Table 1, because the model in Table 1 is predicting the data on which it 
was estimated, whereas the model in Table 3 is predicting out of sample data.  
5. Discussion 
In this paper we have developed a Bayesian nonparametric model for estimating the 
utility values of health states defined by the EQ-5D generic descriptive system., in 
order to generate QALYs and hence to conduct cost utility analysis of health care 
interventions. We believe our model is simpler, a better fit, predicts validly and more 
meaningfully than the previous analysis of Johnson et al (2005). 
The most important difference between our analysis and that of Johnson et al (2005) 
is the way that our model identifies distinct, interpretable aspects of the differences 
between the UK and US population valuations of EQ-5D.  The dominant effect is the 
US covariate, whose positive value means that US respondents generally place higher 
utility on all the health states.  Because of the multiplicative way that covariates enter 
our model, this fits the data better since the difference between the two countries is 
negligible for good health states and at its greatest for the poorest health state (33333).  
Johnson et al found the same effect, but only through estimating a very large number 
of parameters, whereas our model clearly shows this through a single dominant term.  
It is this parameter that can be seen in the steady trend of the line marked with 
triangles in Figure 1 or the steady deviation of the points from the solid line in Figure 
8. 
This factor is moderated through a second covariate term, the interaction between US 
and Sex.  We see that this overall tendency to give higher utilities is stronger for 
females than for males, such that whereas there is a clear sex difference in the UK this 
effectively disappears in US respondents. Finally, we have seen that the US 
respondents are more sensitive to poor health in mobility and self care, but less 
sensitive in the dimensions of usual activities, pain and anxiety.  These differences are 
small but emerge clearly in the analysis. 
In contrast, Johnson et al (2005) model national/cultural differences through fitting 
separate US and UK parameters for every level (above 1) of every dimension.  
Through estimating many more parameters, their analysis is susceptible to over-fitting 
and data artefacts (which we believe can be seen in the more disordered behaviour in 
Figures 7 and 9 i.e. the non steady trend of the line marked with triangles in Figure 7 13
and the non steady deviation of the points from the solid line in Figure 9).  It is also 
more difficult to interpret.   
The novel part of the analysis was to use the covariate framework of the Bayesian 
model to represent the differences between the two countries. Understanding this will 
be hugely important in terms of reducing the need for instruments to be valued 
separately in each country.It is shown that, although the model gives satisfactory 
results for the US and UK separate fits, the combined analysis is better and so the use 
of the interactions terms as covariates is an acceptable model. This implies that the 
US and UK should use the combined data rather than their own ones.  
In conclusion, we found meaningful country-specific differences in directly elicited 
TTO valuations of EQ-5D health states between the US and UK general populations. 
The differences in valuations depend on the degree of severity of the health state. The 
simple idea of a covariate to represent the US and UK is adequate and hugely 
important in terms of reducing the need for EQ-5D to be valued separately in each 
country. The model is applicable to other generic health state descriptive systems such 
as SF-6D and HUI-II, as well as to more specialised, disease-specific systems.  14
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Table 1: Predicted statistics for 42 health states in the US and UK General population 
US UK  Health  





11111 1 0 1 0 0 0 0 
11121 0.8689 0.0076 0.8146 0.0089 0.0543 0.03 0.0243 
21111 0.8708 0.0071 0.859 0.0087 0.0118 -0.01 0.0218 
11211 0.8702 0.0067 0.8379 0.0084 0.0323 -0.004 0.0363 
12111 0.8278 0.0076 0.8104 0.0088 0.0174 0.005 0.0124 
11112 0.8375 0.0066 0.783 0.0083 0.0545 -0.002 0.0565 
12121 0.7648 0.0095 0.7062 0.0113 0.0586 0.04 0.0186 
12211 0.769 0.0088 0.7328 0.0105 0.0362 0.01 0.0262 
11122 0.7613 0.0094 0.6633 0.0117 0.098 0.03 0.068 
22121 0.6698 0.0091 0.6069 0.0114 0.0629 0.08 -0.0171 
22112 0.6748 0.0099 0.6175 0.0117 0.0573 0.03 0.0273 
22122 0.6045 0.0107 0.5048 0.0126 0.0997 0.12 -0.0203 
21222 0.6151 0.0092 0.4953 0.0127 0.1198 0.1 0.0198 
12222 0.6091 0.0089 0.4897 0.0121 0.1194 0.09 0.0294 
11312 0.5987 0.0097 0.4866 0.0119 0.1121 0.07 0.0421 
21312 0.5699 0.0102 0.4644 0.0126 0.1055 0.07 0.0355 
22222 0.5463 0.0103 0.428 0.0139 0.1183 0.07 0.0483 
11113 0.483 0.0095 0.344 0.0119 0.139 0.11 0.029 
13212 0.4168 0.0097 0.3094 0.0126 0.1074 0.07 0.0374 
13311 0.3594 0.0097 0.2594 0.0126 0.1 0.05 0.05 
12223 0.3574 0.0107 0.1706 0.0145 0.1868 0.18 0.0068 
21232 0.231 0.0114 0.0171 0.0155 0.2139 0.25 -0.0361 
21323 0.2714 0.0118 0.0599 0.0164 0.2115 0.14 0.0715 
23321 0.2341 0.0106 0.0939 0.0153 0.1402 0.14 0.0002 
11131 0.2909 0.0102 0.1105 0.0136 0.1804 0.08 0.1004 
22323 0.1889 0.0116 -0.0234 0.0174 0.2123 0.22 -0.0077 
32211 0.1864 0.0107 0.0769 0.0141 0.1095 0.06 0.0495 
22331 0.108 0.011 -0.0966 0.0174 0.2046 0.17 0.0346 
11133 0.1432 0.0107 -0.1135 0.0156 0.2567 0.2 0.0567 
21133 0.1057 0.0114 -0.1459 0.0175 0.2516 0.2 0.0516 
23313 0.0767 0.0111 -0.1105 0.0165 0.1872 0.14 0.0472 
23232 0.0448 0.0126 -0.1743 0.0184 0.2191 0.15 0.0691 
22233 0.0452 0.0131 -0.2125 0.0184 0.2577 0.19 0.0677 
33212 0.0313 0.0115 -0.117 0.0161 0.1483 0.05 0.0983 
32223 -0.0089 0.0127 -0.2334 0.0184 0.2245 0.19 0.0345 
13332 -0.0375 0.0121 -0.2906 0.0196 0.2531 0.19 0.0631 
32313 -0.0302 0.0122 -0.2364 0.0175 0.2062 0.11 0.0962 
33321 -0.0473 0.0116 -0.2225 0.0176 0.1752 0.07 0.1052 
32232 -0.0395 0.0137 -0.2739 0.0187 0.2344 0.16 0.0744 
32331 -0.1149 0.0134 -0.3449 0.0197 0.23 0.13 0.1 
33232 -0.1446 0.0143 -0.3836 0.0206 0.239 0.15 0.089 
33323 -0.1845 0.0134 -0.4342 0.0214 0.2497 0.16 0.0897 
33333 -0.2671 0.0122 -0.5613 0.0217 0.2942 0.17 0.1242 18
Figure 1. Predicted mean health state valuations for the US and UK populations using 
the Bayesian model 
Figure 2. Posterior distribution of the covariates 19
Figure 3. Posterior distribution of the interaction terms  
Figure 4. Mean TTO utility values by age for pits state: US and UK 20
Figure 5. Posterior distribution of the underlying regression parameters   and 
Figure 6. Posterior distributions of the corresponding   and 21
Figure 7. Mean valuations for the US and UK populations (Johnson et al model) 
Figure 8. Relationship between the US and UK predicted mean valuations of the 43 
EQ-5D health states for the Bayesian model 22
Figure 9. Relationship between the US and UK predicted mean valuations of the 43 
EQ-5D health states for the Johnson et al model 
Figure 10.  Standardised residuals for each of the 81240 individual health state valuation23
Table 2: Johnson et al (2005) random effect model of US and UK EQ-5D valuations. 
    Main effects plus 
 Main Effects Only interaction terms 
CoefficientP value CoefficientP value 
Intercept 0.576  0.645  
US 0.095  0.011 0.854 
Age 0.011  0.012  
Age2 -0.0001  -0.0001  
Sex 0.028 0.022 0.057  
M2 -0.052  -0.073  
M3 -0.342  -0.333  
S2 -0.07  -0.084  
S3 -0.232  -0.229  
U2 -0.09  -0.122  
U3 -190  -0.228  
P2 -0.056  -0.093  
P3 -0.373  -0.454  
A2 -0.055  -0.078  
A3 -0.258  -0.322  
US*Age   -0.001 0.707 
US*Age2  <0.0001 0.697 
US*Sex   -0.035 0.062 
US*M2   0.026 0.0003 
US*M3   -0.009 0.437 
US*S2   0.016 0.019 
US*S3   -0.003 0.752 
US*U2   0.04  
US*U3   0.047  
US*P2   0.044  
US*P3   0.097  
US*A2   0.028 0.0002 
US*A3   0.077  
Table 3: Prediction of reserved data means 
Missing state True Sample mean Posterior Mean Posterior S.D. 
12121 0.7641 0.7139 0.0902 
22331 0.1109 0.065 0.1146 
33232 -0.2228 -0.2028 0.1019 
R.M.S.E. 0.040   